{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:04:23Z","timestamp":1761102263715,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["APP1079897"],"award-info":[{"award-number":["APP1079897"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3485-0","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T09:20:07Z","timestamp":1500369607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3905-3025","authenticated-orcid":false,"given":"Tatiane","family":"Yanes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bettina","family":"Meiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary-Anne","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajneesh","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Barlow-Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Roscioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"key":"3485_CR1","unstructured":"Australian Institute of Health and Welfare. Premature mortality from chronic disease. Bulletin no.84. 2010. Cat. no. AUS 133; 20pp. \nhttp:\/\/www.aihw.gov.au\/publication-detail\/?id=6442472466\n\n. Accessed 06 July 2016"},{"issue":"9291","key":"3485_CR2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","volume":"358","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2001","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet. 2001;358(9291):1389\u201399.","journal-title":"Lancet"},{"issue":"9","key":"3485_CR3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"S Domchek","year":"2010","unstructured":"Domchek S, Friebel T, Singer C. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967\u201375.","journal-title":"JAMA"},{"key":"3485_CR4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"T Rebbeck","year":"2009","unstructured":"Rebbeck T, Kauff N, Domchek S. Meta-analysis of risk reduction estimates associated with risk-reducing Salpingooophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009;101:80\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"3485_CR5","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2008.20.5179","volume":"27","author":"K Visvanathan","year":"2009","unstructured":"Visvanathan K, Hurley P, Chlebowski R, Col N, Ropka M, Collyar D, et al. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacological interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol. 2009;27(19):3235\u201358.","journal-title":"J Clin Oncol"},{"issue":"3","key":"3485_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/B:JOMG.0000048770.90334.3b","volume":"9","author":"D Thompson","year":"2004","unstructured":"Thompson D, Easton D. The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia. 2004;9(3):221\u201336.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"3485_CR7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10897-011-9462-x","volume":"21","author":"BD Riley","year":"2012","unstructured":"Riley BD, Culver JO, Skrzynia C, Senter LA, Peters JA, Costalas JW, et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of genetic counselors. J Genet Couns. 2012;21(2):151\u201361.","journal-title":"J Genet Couns"},{"key":"3485_CR8","doi-asserted-by":"crossref","unstructured":"Mavaddat N, Pharoah PDP, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants. J Natl Cancer Inst. 2015;107(5):djv036.","DOI":"10.1093\/jnci\/djv036"},{"issue":"35","key":"3485_CR9","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1200\/JCO.2012.41.7469","volume":"30","author":"S Sawyer","year":"2012","unstructured":"Sawyer S, Mitchell G, McKinley J, Chenevix-Trench G, Beesley J, Chen X, et al. A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol. 2012;30(35):4330\u20136.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3485_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/gim.2016.43","volume":"19","author":"H Li","year":"2017","unstructured":"Li H, Feng B, Miron A, Chen X, Beesley J, Bimeh E, et al. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab. Genet Med. 2017;19(1):30\u20135.","journal-title":"Genet Med"},{"issue":"2","key":"3485_CR11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1158\/1055-9965.EPI-15-0838","volume":"25","author":"GS Dite","year":"2016","unstructured":"Dite GS, MacInnis RJ, Bickerstaffe A, Dowty JG, Allman R, Apicella C, et al. Breast cancer risk prediction using clinical models and 77 independent risk-associated SNPs for women aged under 50 years: Australian breast cancer family registry. Cancer Epidemiol Biomark Prev. 2016;25(2):359\u201365.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"3485_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10549-016-3897-6","volume":"158","author":"TA Muranen","year":"2016","unstructured":"Muranen TA, Mavaddat N, Khan S, Fagerholm R, Pelttari L, Lee A, et al. Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families. Breast Cancer Res Treat. 2016;158(3):463\u20139.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"3485_CR13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ng.586","volume":"42","author":"C Turnbull","year":"2010","unstructured":"Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 2010;42(6):504\u20137.","journal-title":"Nat Genet"},{"issue":"4","key":"3485_CR14","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ajpath.2013.07.003","volume":"183","author":"M Ghoussaini","year":"2013","unstructured":"Ghoussaini M, Pharoah P, Easton D. Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning? Am J Pathol. 2013;183(4):1038\u201351.","journal-title":"Am J Pathol"},{"issue":"4","key":"3485_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng.2563","volume":"45","author":"K Michailidou","year":"2013","unstructured":"Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013;45(4):353\u201361. 61e1-2","journal-title":"Nat Genet"},{"issue":"4","key":"3485_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ng.3242","volume":"47","author":"K Michailidou","year":"2015","unstructured":"Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet. 2015;47(4):373\u201380.","journal-title":"Nat Genet"},{"key":"3485_CR17","unstructured":"National Institure for Clinical Excellence (NICE). Familial breast cancer: Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. 2015. \nhttp:\/\/guidance.nice.org.uk\/CG164\n\n. Accessed 11 July 2016."},{"key":"3485_CR18","unstructured":"eviQ Cancer Treatments Online. Cancer Institute NSW. Risk Management for Unaffected Women at Moderately Increased Risk of Breast Cancer. 2016. ID: 001424 (V.2). \nhttps:\/\/www.eviq.org.au\/Category\/tabid\/65\/categoryid\/66\/Default.aspx\n\n. Accessed 11 July 2016."},{"key":"3485_CR19","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/pon.933","volume":"14","author":"B Meiser","year":"2005","unstructured":"Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology. 2005;14:1060\u201374.","journal-title":"Psychooncology"},{"issue":"4","key":"3485_CR20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1037\/a0014778","volume":"28","author":"JG Hamilton","year":"2009","unstructured":"Hamilton JG, Lobel M, Moyer A. Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol. 2009;28(4):510\u20138.","journal-title":"Health Psychol"},{"key":"3485_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1023\/B:FAME.0000026820.32469.4a","volume":"3","author":"JG Reichelt","year":"2004","unstructured":"Reichelt JG, Heimdal K, Moller P, Dahl AA. BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Familial Cancer. 2004;3:21\u20138.","journal-title":"Familial Cancer"},{"issue":"2","key":"3485_CR22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1200\/JCO.2002.20.2.514","volume":"20","author":"M Schwartz","year":"2002","unstructured":"Schwartz M, Peshkin B, Hughs C, Main D, Isaacs C, Lerman C. Impact of BRCA1\/BRCA2 mutation testing on psychological distress in a clinic-based sample. J Clin Oncol. 2002;20(2):514\u201320.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3485_CR23","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajmg.a.20374","volume":"124","author":"MS Roosmalen van","year":"2004","unstructured":"van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, et al. Impact of BRCA1\/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet A. 2004;124(4):346\u201355.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"3485_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/gte.2006.0527","volume":"11","author":"TA Beery","year":"2007","unstructured":"Beery TA, Williams JK. Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders. Genet Test. 2007;11(2):111\u201323.","journal-title":"Genet Test"},{"issue":"2","key":"3485_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/10906570260199320","volume":"6","author":"N Hallowell","year":"2002","unstructured":"Hallowell N, Foster C, Ardern-Jones A, Eeles R, Murday V, Watson M. Genetic testing for women previously diagnosed with breast\/ovarian cancer: examining the impact of BRCA1 and BRCA2 mutation searching. Genet Test. 2002;6(2):79\u201387.","journal-title":"Genet Test"},{"issue":"1","key":"3485_CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000356567","volume":"17","author":"AE Anderson","year":"2014","unstructured":"Anderson AE, Flores KG, Boonyasiriwat W, Gammon A, Kohlmann W, Birmingham WC, et al. Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk. Public Health Genom. 2014;17(1):48\u201360.","journal-title":"Public Health Genom."},{"issue":"1","key":"3485_CR27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s10897-012-9530-x","volume":"22","author":"K-G Leventhal","year":"2013","unstructured":"Leventhal K-G, Tuong W, Peshkin BN, Salehizadeh Y, Fishman MB, Eggly S, et al. \u201cis it really worth it to get tested?\u201d: primary care patients\u2019 impressions of predictive SNP testing for colon cancer. J Genet Couns. 2013;22(1):138\u201351.","journal-title":"J Genet Couns"},{"issue":"3","key":"3485_CR28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000324703","volume":"14","author":"KD Graves","year":"2011","unstructured":"Graves KD, Peshkin BN, Luta G, Tuong W, Schwartz MD. Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Public Health Genom. 2011;14(3):178\u201389.","journal-title":"Public Health Genom"},{"issue":"5","key":"3485_CR29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s10897-014-9803-7","volume":"24","author":"R Howe","year":"2015","unstructured":"Howe R, Miron-Shatz T, Hanoch Y, Omer ZB, O\u2019Donoghue C, Ozanne EM. Personalized medicine through SNP testing for breast cancer risk: clinical implementation. J Genet Couns. 2015;24(5):744\u201351.","journal-title":"J Genet Couns"},{"issue":"1","key":"3485_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13053-014-0023-9","volume":"13","author":"MJ Hall","year":"2015","unstructured":"Hall MJ, Ruth KJ, Chen DY, Gross LM, Giri VN. Interest in genomic SNP testing for prostate cancer risk: a pilot survey. Hered Cancer Clin Pract. 2015;13(1):1\u20139.","journal-title":"Hered Cancer Clin Pract"},{"issue":"1","key":"3485_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13142-012-0149-0","volume":"3","author":"R Nusbaum","year":"2013","unstructured":"Nusbaum R, Leventhal K-G, Hooker GW, Peshkin BN, Butrick M, Salehizadeh Y, et al. Translational genomic research: protocol development and initial outcomes following SNP testing for colon cancer risk. Transl Behav Med. 2013;3(1):17\u201329.","journal-title":"Transl Behav Med"},{"issue":"2","key":"3485_CR32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ygeno.2013.04.002","volume":"102","author":"KD Graves","year":"2013","unstructured":"Graves KD, Leventhal K-G, Nusbaum R, Salehizadeh Y, Hooker GW, Peshkin BN, et al. Behavioral and psychosocial responses to genomic testing for colorectal cancer risk. Genomics. 2013;102(2):123\u201330.","journal-title":"Genomics"},{"key":"3485_CR33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/pmed.2002.1110","volume":"35","author":"A Helmes","year":"2002","unstructured":"Helmes A. Application of the protection motivation theory to genetic testing for breast cancer risk. Prev Med. 2002;35:453\u201362.","journal-title":"Prev Med"},{"key":"3485_CR34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ypmed.2012.08.008","volume":"55","author":"A Fisher","year":"2012","unstructured":"Fisher A, Bonner C, Biankin A, Juraskova I. Factors influencing intention to undergo whole genome screening in future healthcare: a single-blind parallel-group randomised trial. Prev Med. 2012;55:514\u201320.","journal-title":"Prev Med"},{"issue":"4","key":"3485_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/GIM.0b013e3181993175","volume":"11","author":"N Kasparian","year":"2009","unstructured":"Kasparian N, Meiser B, Butow P, Simpson J, Mann G. Predictive genetic testing for melanoma risk: a three-year prospective cohort study of uptake and outcomes amongst Australian families. Genet Med. 2009;11(4):265\u201378.","journal-title":"Genet Med"},{"key":"3485_CR36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/0887044021000054764","volume":"17","author":"D Braithwaite","year":"2002","unstructured":"Braithwaite D, Sutton S, Steggles N. Intention to participate in predictive genetic testing for hereditary cancer: the role of attitude toward uncertainty. Psycholology and Health. 2002;17:761\u201372.","journal-title":"Psycholology and Health"},{"key":"3485_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0447.1990.tb01360.x","volume":"82","author":"T Brugha","year":"1990","unstructured":"Brugha T, Cragg D. The list of threatening experiences: the reliability and validity of a brief life events a a questionnaire. Acta Psychiatr Scand. 1990;82:77\u201381.","journal-title":"Acta Psychiatr Scand"},{"key":"3485_CR38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006842-197905000-00004","volume":"41","author":"M Horowitz","year":"1979","unstructured":"Horowitz M, Wilner N, Alvarez W. Impact of events scale: a measure of subjective stress. Psychosom Med. 1979;41:209\u201318.","journal-title":"Psychosom Med"},{"issue":"6","key":"3485_CR39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pon.533","volume":"10","author":"B Thewes","year":"2001","unstructured":"Thewes B, Meiser B, Hickie I. Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psychooncology. 2001;10(6):459\u201368.","journal-title":"Psychooncology"},{"issue":"2","key":"3485_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale: an updated literature review. J Psychosom Res. 2002;52(2):69\u201377.","journal-title":"J Psychosom Res"},{"key":"3485_CR41","unstructured":"Cancer Australia. Australian Government. Early detection of breast cancer. 2004. \nhttps:\/\/canceraustralia.gov.au\/publications-and-resources\/position-statements\/early-detection-breast-cancer\n\n. Accessed 19 July 2016."},{"key":"3485_CR42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10549-010-0868-1","volume":"124","author":"M Price","year":"2010","unstructured":"Price M, Butow P, Charles M, Bullen T, Meiser B, McKinley J, et al. Predictors of breast cancer screening behavior in women with a strong family history of the disease. Breast Cancer Res Treat. 2010;124:509\u201319.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"3485_CR43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X03256005","volume":"23","author":"JC Brehaut","year":"2003","unstructured":"Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, et al. Validation of a decision regret scale. Med Decis Mak. 2003;23(4):281\u201392.","journal-title":"Med Decis Mak"},{"issue":"6","key":"3485_CR44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1037\/0278-6133.21.6.564","volume":"21","author":"D Cella","year":"2002","unstructured":"Cella D, Chang C, Peterman A, Wenzel L, Marcus A, Hughes C, et al. A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychol. 2002;21(6):564\u201372.","journal-title":"Health Psychol"},{"issue":"5","key":"3485_CR45","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10897-012-9486-x","volume":"21","author":"JL Waxler","year":"2012","unstructured":"Waxler JL, O\u2019Brien KE, Delahanty LM, Meigs JB, Florez JC, Park ER, et al. Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders. J Genet Couns. 2012;21(5):684\u201391.","journal-title":"J Genet Couns"},{"issue":"2","key":"3485_CR46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1751-7893.2008.00062.x","volume":"2","author":"JC Austin","year":"2008","unstructured":"Austin JC, Honer WG. Psychiatric genetic counselling for parents of individuals affected with psychotic disorders: a pilot study. Early Interv Psychiatry. 2008;2(2):80\u20139.","journal-title":"Early Interv Psychiatry"},{"issue":"6","key":"3485_CR47","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/bjc.2012.61","volume":"106","author":"M Peate","year":"2012","unstructured":"Peate M, Meiser B, Cheah BC, Saunders C, Butow P, Thewes B, et al. Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. Br J Cancer. 2012;106(6):1053\u201361.","journal-title":"Br J Cancer"},{"issue":"15","key":"3485_CR48","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0959-8049(02)00264-2","volume":"38","author":"B Meiser","year":"2002","unstructured":"Meiser B, Butow P, Friedlander M, Barratt A, Schnieden V, Watson M, et al. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer. 2002;38(15):2025\u201331.","journal-title":"Eur J Cancer"},{"issue":"5","key":"3485_CR49","first-page":"582","volume":"41","author":"GR Norman","year":"2003","unstructured":"Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582\u201392.","journal-title":"Med Care"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3485-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T09:20:31Z","timestamp":1500369631000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3485-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3485"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3485-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2017,7,18]]},"article-number":"491"}}